Total Funding
72
73
Total FundingPost-IPO Equity raised
Growth Score
-12 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10490
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Emily Leproust: Chief Executive OfficerPast Role: Agilent Technologies, Director of Applications & Chemistry R&D—Genomics
Solange Glaize: CFO
About the Company
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries. It produces synthetic DNA used in applications across healthcare, agriculture, industrial chemicals, and data storage. The company develops a silicon-based DNA synthesis platform to enable high-throughput, scalable, and precise
DNA production. Its technology supports research and development in drug discovery and specialty chemical production.
Women Led
